Galderma Group AG Share Price

Equities

GALD

CH1335392721

Personal Products

Market Closed - Swiss Exchange 09:01:54 17/06/2024 pm IST 5-day change 1st Jan Change
73.25 CHF -2.32% Intraday chart for Galderma Group AG -0.14% 0.00%

Financials

Sales 2024 * 4.43B 3.94B 370B Sales 2025 * 4.97B 4.42B 415B Capitalization 20.02B 17.81B 1,672B
Net income 2024 * 206M 183M 17.21B Net income 2025 * 468M 416M 39.09B EV / Sales 2024 * 5.05 x
Net Debt 2024 * 2.35B 2.09B 196B Net Debt 2025 * 1.81B 1.61B 151B EV / Sales 2025 * 4.39 x
P/E ratio 2024 *
102 x
P/E ratio 2025 *
40.6 x
Employees 6,545
Yield 2024 *
0.04%
Yield 2025 *
0.33%
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.32%
1 week-0.14%
Current month-0.03%
1 month-0.85%
More quotes
1 week
72.41
Extreme 72.41
75.70
1 month
71.83
Extreme 71.83
76.20
Current year
60.00
Extreme 60
76.20
1 year
60.00
Extreme 60
76.20
3 years
60.00
Extreme 60
76.20
5 years
60.00
Extreme 60
76.20
10 years
60.00
Extreme 60
76.20
More quotes
Date Price Change Volume
17/24/17 73.25 -2.32% 240 203
14/24/14 74.99 -0.13% 173,500
13/24/13 75.09 +1.65% 212,158
12/24/12 73.87 +1.19% 119,204
11/24/11 73 -0.48% 84,207

Delayed Quote Swiss Exchange, June 17, 2024 at 09:01 pm IST

More quotes
Galderma Group AG is a Switzerland based holding Company, specializing in dermatological treatments and skin care products. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
84.14 USD
Average target price
85.62 USD
Spread / Average Target
+1.76%
Consensus

Annual profits - Rate of surprise